PRTA - Prothena Corporation plc
IEX Last Trade
22.29
0.730 3.275%
Share volume: 300,305
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$21.56
0.73
3.39%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-03 | 2023-02-28 | 2023-05-04 | 2023-08-03 | 2023-11-02 | 2024-02-22 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 549.589 M | 554.440 M | 758.035 M | 741.586 M | 720.649 M | 746.920 M | 696.382 M | 623.194 M | |
| Current Assets | 521.294 M | 524.562 M | 719.098 M | 700.343 M | 677.103 M | 690.604 M | 639.282 M | 565.868 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 12.499 M | 28.934 M | 8.692 M | 14.159 M | 16.116 M | 13.196 M | 13.941 M | 18.004 M | |
| Short Term Investments | 12.499 M | 28.934 M | 8.692 M | 14.159 M | 16.116 M | 13.196 M | 13.941 M | 18.004 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 524.000 K | 5.159 M | 5.159 M | 0.000 | |
| Current Cash | 508.795 M | 495.628 M | 710.406 M | 686.184 M | 659.111 M | 670.897 M | 618.830 M | 546.512 M | |
| Total Non-current Assets | 28.295 M | 29.878 M | 38.937 M | 41.243 M | 43.546 M | 56.316 M | 57.100 M | 57.326 M | |
| Property Plant Equipment | 1.861 M | 1.997 M | 1.731 M | 1.924 M | 2.170 M | 2.433 M | 3.836 M | 3.672 M | |
| Other Assets | 3.784 M | 3.747 M | 10.513 M | 10.955 M | 11.267 M | 10.478 M | 6.349 M | 3.609 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 549.589 M | 554.440 M | 758.035 M | 741.586 M | 720.649 M | 746.920 M | 696.382 M | 623.194 M | |
| Total liabilities | 142.290 M | 149.792 M | 135.993 M | 134.177 M | 138.970 M | 129.693 M | 135.017 M | 120.795 M | |
| Total current liabilities | 40.107 M | 50.598 M | 50.147 M | 48.884 M | 71.565 M | 53.370 M | 56.891 M | 43.266 M | |
| Accounts Payable | 7.551 M | 9.788 M | 9.270 M | 12.523 M | 13.851 M | 19.458 M | 25.391 M | 14.420 M | |
| Other liabilities | 98.905 M | 97.545 M | 85.846 M | 85.293 M | 67.405 M | 67.405 M | 67.405 M | 67.405 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 98.905 M | 97.545 M | 85.846 M | 85.293 M | 67.405 M | 67.405 M | 67.405 M | 67.405 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 407.299 M | 404.648 M | 622.042 M | 607.409 M | 581.679 M | 617.227 M | 561.365 M | 502.399 M | |
| Common stock | 46.805 M | 46.986 M | 48.981 M | 52.501 M | 53.121 M | 53.559 M | 53.683 M | 53.714 M | |
| Retained earnings | -793.588 M | -839.352 M | -833.003 M | -879.867 M | -934.462 M | -912.555 M | -980.031 M | -1.052 B |